Fredrik Erlandsson
Company: Purespring Therapeutics
Job title: Chief Medical Officer
Seminars:
Harnessing Podocyte Gene Therapy to Provide LongTerm Remedies for Kidney Disease 11:00 am
Reviewing gene therapy opportunities in both genetic and nongenetic glomerular disease Feasibility of AAV-based gene therapy for kidney disease Future perspectives on podocyte gene therapyRead more
day: Day 2 Track 2 AM